Birdwatch Archive

Birdwatch Note Rating

2024-04-23 10:37:10 UTC - NOT_HELPFUL

Rated by Participant: D1A753CE83079A8B525BB5BF348FF8789786A0D3C0A129FA5B606BC60359D986
Participant Details

Original Note:

Novo Nordisk spent over $2B in R&D over half a decade to make develop Ozempic. https://en.wikipedia.org/wiki/Semaglutide https://www.macrotrends.net/stocks/charts/NVO/novo-nordisk/research-development-expenses

All Note Details

Original Tweet

All Information

  • noteId - 1774520608384246241
  • participantId -
  • raterParticipantId - D1A753CE83079A8B525BB5BF348FF8789786A0D3C0A129FA5B606BC60359D986
  • createdAtMillis - 1713868630532
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1774520608384246241D1A753CE83079A8B525BB5BF348FF8789786A0D3C0A129FA5B606BC60359D986